{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:58:44Z","timestamp":1765231124552,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["ENMed\/0065\/2016"],"award-info":[{"award-number":["ENMed\/0065\/2016"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["ENMed\/0009\/2015"],"award-info":[{"award-number":["ENMed\/0009\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iMed.ULisboa","award":["UID\/DTP\/04138\/2013"],"award-info":[{"award-number":["UID\/DTP\/04138\/2013"]}]},{"name":"SimInhale","award":["COST Action MP1404"],"award-info":[{"award-number":["COST Action MP1404"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11095-019-2615-6","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T19:05:36Z","timestamp":1555355136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-5540","authenticated-orcid":false,"given":"Carolina","family":"Sousa","sequence":"first","affiliation":[]},{"given":"Lu\u00eds F.","family":"Gouveia","sequence":"additional","affiliation":[]},{"given":"Bruna","family":"Kreutzer","sequence":"additional","affiliation":[]},{"given":"Beatriz","family":"Silva-Lima","sequence":"additional","affiliation":[]},{"given":"Retsepile E.","family":"Maphasa","sequence":"additional","affiliation":[]},{"given":"Admire","family":"Dube","sequence":"additional","affiliation":[]},{"given":"Mafalda","family":"Videira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"issue":"2","key":"2615_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1517\/17460440802661443","volume":"4","author":"DAK Ii","year":"2009","unstructured":"Ii DAK, Meujo DA, Hamann MT. Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites. Expert Opin Drug Discovery. 2009;4(2):109\u201346.","journal-title":"Expert Opin Drug Discovery"},{"key":"2615_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1155\/2012\/950658","volume":"2012","author":"C Naujokat","year":"2012","unstructured":"Naujokat C, Steinhart R. Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol. 2012;2012:44\u20136.","journal-title":"J Biomed Biotechnol"},{"issue":"14","key":"2615_CR3","first-page":"1","volume":"4","author":"DL Mager","year":"2006","unstructured":"Mager DL. Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med. 2006;4(14):1\u201318.","journal-title":"J Transl Med"},{"issue":"257","key":"2615_CR4","first-page":"1","volume":"17","author":"C Jacqueline","year":"2017","unstructured":"Jacqueline C, Tasiemski A, Sorci G, Ujvari B, Maachi F, Miss\u00e9 D, et al. Infections and cancer: the \u201cfifty shades of immunity\u201d hypothesis. BioMed Cent. 2017;17(257):1\u201311.","journal-title":"BioMed Cent"},{"issue":"5","key":"2615_CR5","first-page":"1","volume":"5","author":"NO Martin","year":"2017","unstructured":"Martin NO, Nishiuchi Y, Jonathan Baell J, Franco OL, Fel\u00edcio MR, Silva ON, et al. Peptides with dual antimicrobial and anticancer activities. Front Chem. 2017;5(5):1\u20139.","journal-title":"Front Chem"},{"issue":"33","key":"2615_CR6","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.2174\/15672050113109990199","volume":"20","author":"Shuang Zhou","year":"2013","unstructured":"Zhou S, Wang F, Wong ET, Fonkem E, Hsieh T-C, Wu JM, et al. Salinomycin: a novel anti-Cancer agent with known anti- Coccidial activities. Curr Med Chem. 2013;20(33):4095\u2013101.","journal-title":"Current Medicinal Chemistry"},{"issue":"2","key":"2615_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.bbrc.2013.12.032","volume":"443","author":"Danxin Wu","year":"2014","unstructured":"Wu D, Zhang Y, Huang J, Fan Z, Shi F, Wang S. Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo. Biochem Biophys Res Commun. Elsevier Inc; 2014;443(2):712\u2013717.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"4","key":"2615_CR8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.bbrc.2015.09.108","volume":"466","author":"Hyunsook An","year":"2015","unstructured":"An H, Kim JY, Lee N, Cho Y, Oh E, Seo JH. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. Biochem Biophys Res Commun. Elsevier Ltd; 2015;466(4):696\u2013703.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"2615_CR9","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2147\/OTT.S126463","volume":"10","author":"R Li","year":"2017","unstructured":"Li R, Dong T, Hu C, Lu J, Dai J, Liu P. Salinomycin repressed the epithelial-mesenchymal transition of epithelial ovarian cancer cells voa downregulating Wnt\/B-catenin pathway. OncoTargets and Therapy 2017;10:1317\u201325.","journal-title":"OncoTargets and Therapy"},{"issue":"1","key":"2615_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2013-0314TR","volume":"50","author":"ME Kidd","year":"2014","unstructured":"Kidd ME, Shumaker DK, Ridge KM. The role of vimentin intermediate filaments in the progression of lung cancer. Am J Respir Cell Mol Biol. 2014;50(1):1\u20136.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"2615_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.bbamcr.2013.02.024","volume":"1833","author":"Laura Cogli","year":"2013","unstructured":"Cogli L, Progida C, Bramato R, Bucci C. Vimentin phosphorylation and assembly are regulated by the small GTPase Rab7a. Biochim Biophys Acta, Mol Cell Res Elsevier B.V.; 2013;1833(6):1283\u20131293.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"issue":"3","key":"2615_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.15171\/apb.2017.041","volume":"7","author":"B Mansoori","year":"2017","unstructured":"Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: a brief review. Adv Pharm Bull. 2017;7(3):339\u201348.","journal-title":"Adv Pharm Bull"},{"key":"2615_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4137\/DTI.S12519","volume":"7","author":"L Amin","year":"2013","unstructured":"Amin L. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights. 2013;7:27\u201334.","journal-title":"Drug Target Insights"},{"key":"2615_CR14","unstructured":"Fda, Cder, Purdie, Florine P. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid Oral dosage forms based on a biopharmaceutics classification system guidance for industry. 2017 [cited 2018 Jun 21]; Available from: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm . Accessed 20 June 2018."},{"key":"2615_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.addr.2013.11.004","volume":"66","author":"S Biswas","year":"2014","unstructured":"Biswas S, Torchilin VP. Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev. 2014;66:26\u201341.","journal-title":"Adv Drug Deliv Rev"},{"key":"2615_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2017.04.019","volume":"256","author":"J Li","year":"2017","unstructured":"Li J, Qiao Y. Wu Z. Nanosystem trends in drug delivery using quality-by-design concept. J Control Release. 2017 Jun;256:9\u201318.","journal-title":"J Control Release"},{"issue":"1","key":"2615_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","volume":"26","author":"Syed A.A. Rizvi","year":"2018","unstructured":"Rizvi SAA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. King Saud University; 2017;26(1):64\u201370.","journal-title":"Saudi Pharmaceutical Journal"},{"issue":"1","key":"2615_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10965-017-1426-x","volume":"25","author":"M Almeida","year":"2018","unstructured":"Almeida M, Magalh\u00e3es M, Veiga F, Figueiras A. Poloxamers, poloxamines and polymeric micelles: definition, structure and therapeutic applications in cancer. J Polym Res. 2018;25(1):1\u201314.","journal-title":"J Polym Res"},{"key":"2615_CR19","doi-asserted-by":"crossref","unstructured":"Chowdhury P, Nagesh PKB, Kumar S, Jaggi M, Chauhan SC, Yallapu MM. Bioactivity of engineered nanoparticles. 2017. 207\u2013237 p.","DOI":"10.1007\/978-981-10-5864-6_9"},{"issue":"5","key":"2615_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ajps.2014.06.006","volume":"9","author":"X Ai","year":"2014","unstructured":"Ai X, Zhong L, Niu H, He Z. Thin-film hydration preparation method and stability test of DOX-loaded disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate nanomicelles. Asian J Pharm Sci. 2014;9(5):244\u201350.","journal-title":"Asian J Pharm Sci"},{"key":"2615_CR21","unstructured":"Bastogne T. Quality-by-design of nanopharmaceuticals. A state of the art. In: Bridging communitie in the field of nanomedicine. European Commission JRC ; 2017. p. 1\u201312."},{"issue":"1-2","key":"2615_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0021-9673(99)00044-8","volume":"835","author":"Guglielmo Dusi","year":"1999","unstructured":"Dusi G, Gamba V. Liquid chromatography with ultraviolet detection of lasalocid, monensin, salinomycin and narasin in poultry feeds using pre-column derivatization. J Chromatogr A. Elsevier; 1999;835(1\u20132):243\u2013246.","journal-title":"Journal of Chromatography A"},{"key":"2615_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-8155-2025-2.10003-4","volume-title":"Handbook of Non-Invasive Drug Delivery Systems","author":"Guang Wei Lu","year":"2010","unstructured":"Lu GW, Gao P. Emulsions and microemulsions for topical and transdermal drug delivery. In: Handbook of non-invasive drug delivery systems: Elsevier; 2010. p. 59\u201394."},{"key":"2615_CR24","doi-asserted-by":"crossref","unstructured":"Shaarani S, Hamid SS, Mohd Kaus NH. The influence of Pluronic F68 and F127 Nanocarrier on physicochemical properties, in vitro release, and Antiproliferative activity of Thymoquinone drug. Pharmacognosy res. 2017;9(1):12\u201320.","DOI":"10.4103\/0974-8490.199774"},{"key":"2615_CR25","unstructured":"Sotoudegan F, Amini M, Faizi M, Aboofazeli R. Nimodipine-loaded Pluronic\u00ae block copolymer micelles: preparation, characterization, in-vitro and in-vivo studies. Iran J Pharm Res IJPR. Shahid Beheshti University of Medical Sciences; 2016;15(4):641\u2013661."},{"issue":"2-3","key":"2615_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0168-3659(01)00299-1","volume":"73","author":"Vladimir P. Torchilin","year":"2001","unstructured":"Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release Elsevier; 2001;73(2\u20133):137\u2013172.","journal-title":"Journal of Controlled Release"},{"issue":"12","key":"2615_CR27","doi-asserted-by":"publisher","first-page":"19435","DOI":"10.3390\/molecules191219435","volume":"19","author":"Micha\u0142 Antoszczak","year":"2014","unstructured":"Antoszczak M, Maj E, Napi\u00f3rkowska A, Stefa\u0144ska J, Augustynowicz-Kope\u0107 E, Wietrzyk J, et al. Synthesis, anticancer and antibacterial activity of salinomycin N-benzyl amides. Molecules. 2014;19(12):19435\u201359.","journal-title":"Molecules"},{"key":"2615_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2147\/IDR.S156995","volume":"11","author":"I Ghai","year":"2018","unstructured":"Ghai I, Ghai S. Understanding antibiotic resistance via outer membrane permeability. Infect Drug Resist. 2018;11:523\u201330.","journal-title":"Infect Drug Resist"},{"key":"2615_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2013.00321","volume":"3","author":"D Fu","year":"2013","unstructured":"Fu D, Nobili S, William Murray B. Where is it and how does it get there \u2013 intracellular localization and traffic of P-glycoprotein. Front Oncol. 2013;3:1\u20135.","journal-title":"Front Oncol"},{"issue":"3","key":"2615_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1128\/AAC.46.3.755-761.2002","volume":"46","author":"KL Mealey","year":"2002","unstructured":"Mealey KL, Barhoumi R, Burghardt RC, Safe S, Kochevar DT. Doxycycline induces expression of P glycoprotein in MCF-7 breast carcinoma cells. Antimicrob Agents Chemother. 2002;46(3):755\u201361.","journal-title":"Antimicrob Agents Chemother"},{"key":"2615_CR31","first-page":"1339","volume":"3","author":"MA Ihnat","year":"1997","unstructured":"Ihnat MA, Lariviere JP, Warren AJ, La RN, Blaxall JRN, Pierre KM, et al. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Clin Cancer Res. 1997;3:1339\u201346.","journal-title":"Clin Cancer Res"},{"key":"2615_CR32","first-page":"89","volume":"28","author":"Z Sulov\u00e1","year":"2009","unstructured":"Sulov\u00e1 Z, \u0160ere\u0161 M, Baran\u010d\u00edk M, Gibalov\u00e1 L, Uhr\u00edk B, Polekov\u00e1 L, et al. Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis. Gen Physiol Biophys. 2009;28:89\u201395.","journal-title":"Gen Physiol Biophys"},{"issue":"3","key":"2615_CR33","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.3892\/or.2015.4509","volume":"35","author":"A Hermawan","year":"2016","unstructured":"Hermawan A, Wagner E, Roidl A. Consecutive salinomycin treatment reduces doxorubicin resistance of breast tumor cells by diminishing drug efflux pump expression and activity. Oncol Rep. 2016;35(3):1732\u201340.","journal-title":"Oncol Rep"},{"issue":"10","key":"2615_CR34","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1345\/aph.1E068","volume":"38","author":"Monica A Summers","year":"2004","unstructured":"Summers MA, Moore JL, McAuley JW. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Ann Pharmacother. SAGE PublicationsSage CA: Los Angeles, CA; 2004;38(10):1631\u20131634.","journal-title":"Annals of Pharmacotherapy"},{"issue":"3","key":"2615_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ygyno.2013.03.005","volume":"129","author":"Soshi Kusunoki","year":"2013","unstructured":"Kusunoki S, Kato K, Tabu K, Inagaki T, Okabe H, Kaneda H, et al. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecol Oncol. 2013 Jun;129(3):598\u2013605.","journal-title":"Gynecologic Oncology"},{"issue":"7","key":"2615_CR36","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.apjtm.2015.06.004","volume":"8","author":"Hu Qu","year":"2015","unstructured":"Qu H, Ma B, Yuan H-F, Wang Z-Y, Guo S-J, Zhang J. Effect of salinomycin on metastasis and invasion of bladder cancer cell line T24. Asian Pac J Trop Med No longer published by Elsevier; 2015;8(7):578\u2013582.","journal-title":"Asian Pacific Journal of Tropical Medicine"},{"issue":"4","key":"2615_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/onc.2010.421","volume":"30","author":"Q-S Zhu","year":"2010","unstructured":"Zhu Q-S, Rosenblatt K, Huang K-L, Lahat G, Brobey R, Bolshakov S, et al. Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene. 2011;30(4):457\u201370.","journal-title":"Oncogene"},{"key":"2615_CR38","doi-asserted-by":"crossref","unstructured":"Rai G, Suman S, Mishra S, Shukla Y. Evaluation of growth inhibitory response of resveratrol and Salinomycin combinations against triple negative breast cancer cells. Biomed Pharmacother. Elsevier Masson; 2017 May 1;89:1142\u20131151.","DOI":"10.1016\/j.biopha.2017.02.110"},{"issue":"18","key":"2615_CR39","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68(18):3033\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"2615_CR40","doi-asserted-by":"crossref","unstructured":"Kuo SZ, Blair KJ, Rahimy E, Kiang A, Abhold E, Fan J-B, et al. Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt. BMC Cancer. 2012;12(1):556.","DOI":"10.1186\/1471-2407-12-556"},{"issue":"6","key":"2615_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5468\/ogs.2014.57.6.501","volume":"57","author":"HG Lee","year":"2014","unstructured":"Lee HG, Lee JM, Shin SJ, Kwon SH, Lee GS, Song CH. Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells. Obstet Gynecol Sci 2014;57(6):501\u20136.","journal-title":"Obstet Gynecol Sci"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2615-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2615-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2615-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:50:29Z","timestamp":1663289429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2615-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["2615"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2615-6","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2019,4,15]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"83"}}